Lokavant
Edit

Lokavant

https://www.lokavant.com/
Last activity: 11.06.2024
Active
Categories: HumanTime
Bring the best in artificial intelligence and human insight to let you see and solve risks before they happen, keeping your study on time and on budget.
Mentions
10
Total raised: $29M

Investors 1

DateNameWebsite
-Roivantroivant.co...

Funding Rounds 2

DateSeriesAmountInvestors
05.10.2023-$8M-
08.12.2022-$21M-

Mentions in press and media 10

DateTitleDescription
11.06.2024Lokavant Launches AI Solution to Optimize Clinical Trial FeasibilityNew solution supports trial feasibility prediction, optimization, and control throughout the trial Lokavant, the clinical trial intelligence platform company, announced Spectrum, the first AI clinical trial feasibility software solution for...
05.10.2023Lokavant Raises $8M in FundingLokavant, a NYC-based clinical trial intelligence platform company, raised $8M in funding. The round, which brought the total amount to $29M, saw participation from Mitsui & Co, Edison Partners and Roivant Sciences (Nasdaq: ROIV). The c...
26.04.2023Implementing Clinical Trial Analytics to Predict Trial Outcomes, Upcoming Webinar Hosted by XtalksAs clinical operations teams become leaner and more cost-constrained, there is a growing demand for more advanced clinical trial analytics tools to better manage fragmented data. TORONTO (PRWEB) April 26, 2023 Over the past decade, clinical...
08.12.2022Clinical trial data platform Lokavant raises $21MThe company provides a data analytics platform for clinical trials Not only have the number of clinical trials nearly quadrupled since 2010, going from under 100,000 to over 350,000, but they are also becoming more complex, requiring major ...
07.12.2022Lokavant raises $21M for clinical trial data platformPhoto: JAY DAVISON/Getty Images
07.12.2022Lokavant Raises $21M in FundingLokavant, a Princeton, NJ-based clinical trial intelligence company raised $21M in funding. The round was led by Edison Partners with participation from Roivant Sciences (Nasdaq: ROIV). As part of the transaction, Edison’s General Partner, ...
22.12.2021Lokavant Expands Global Customer Base and Bolsters Leadership TeamNEW YORK, Dec. 22, 2021 /PRNewswire/ -- Lokavant significantly expands enterprise partnership with largest Japanese CRO Lokavant forms new partnership with leading global consultancy to drive digital transformation in life sciences Lokavant...
25.03.2021THREAD and Lokavant Partner to Provide Sponsors with First DCT Benchmarking Solution
11.02.2021Joint Study Shows Decentralized Clinical Trials More Resilient than Traditional Trials During Global PandemicCARY, N.C. and NEW YORK, Feb. 11, 2021 /PRNewswire/ -- THREAD, a global decentralized clinical trials (DCTs) and eCOA provider, and Lokavant, a leading clinical trial intelligence company, today announced the results of a joint analysis dem...
-Lokavant“Bring the best in artificial intelligence and human insight to let you see and solve risks before they happen, keeping your study on time and on budget.”

Reviews 0

Sign up to leave a review

Sign up Log In